Marketing-authorisation holder · Spain
Laboratorio Stada S.L.
838 medicines in 1 country, as authorisation holder and marketer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Spain
838 medicines in 1 country, as authorisation holder and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 838
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| A.A.S. 100 mg COMPRIMIDOS100 mg · Comprimido | Acetylsalicylic acid | Spain | Marketed | 1966 |
| A.A.S. 500 mg COMPRIMIDOS500 mg · Comprimido | Acetylsalicylic acid | Spain | Marketed | 1966 |
| ABIRATERONA STADA 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG500 mg · Comprimido recubierto con película | Abiraterone | Spain | Marketed | 2021 |
| ACECLOFENACO STADA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG100 mg · Comprimido recubierto con película | Aceclofenac | Spain | Marketed | 2015 |
| ACETILCISTEINA STADA 600 mg COMPRIMIDOS EFERVESCENTES EFG600 mg · Comprimido efervescente | Acetylcysteine | Spain | Marketed | 2006 |
| ACICLOVIR STADA 200 MG COMPRIMIDOS EFG200.00 mg · Comprimido | Aciclovir | Spain | Marketed | 1999 |
| ACICLOVIR STADA 50 MG/G CREMA5000 mg · Crema | Aciclovir | Spain | Marketed | 1999 |
| ACICLOVIR STADA 800 MG COMPRIMIDOS EFG800.00 mg · Comprimido | Aciclovir | Spain | Marketed | 1999 |
| ACIDO ACETILSALICILICO STADA 100 MG COMPRIMIDOS GASTRORRESISTENTES EFG100,00 mg · Comprimido gastrorresistente | Acetylsalicylic acid | Spain | Marketed | 2012 |
| ACIDO ALENDRONICO SEMANAL STADA 70 mg COMPRIMIDOS EFG91,36 mg · Comprimido | Alendronic acid | Spain | Marketed | 2005 |
| ACIDO IBANDRONICO STADA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG150 mg · Comprimido recubierto con película | Ibandronic acid | Spain | Marketed | 2012 |
| ACIDO MICOFENOLICO STADA 180 MG COMPRIMIDOS GASTRORRESISTENTES EFG192,350 mg · Comprimido gastrorresistente | Mycophenolate mofetil | Spain | Marketed | 2015 |
| ACIDO MICOFENOLICO STADA 360 MG COMPRIMIDOS GASTRORRESISTENTES EFG384,700 mg · Comprimido gastrorresistente | Mycophenolate mofetil | Spain | Marketed | 2015 |
| AGOMELATINA STADA 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG44.739 mg · Comprimido recubierto con película | Agomelatina acido citrico | Spain | Marketed | 2018 |
| ALFUZOSINA STADA 10 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG10,00 mg · Comprimido de liberación prolongada | Alfuzosin | Spain | Marketed | 2006 |
| ALGESAL 10 MG/G + 100 MG/G ESPUMA CUTANEA100 mg + 10,00 mg · Espuma cutánea | Diethylamine salicylate, Mirtecaina laurilsulfato | Spain | Marketed | 1976 |
| ALGESAL ACTIVADO 10 MG/G + 100 MG/G POMADA10 mg + 100 mg · Pomada | Mirtecaina, Diethylamine salicylate | Spain | Marketed | 1971 |
| ALMAGATO STADAPHARM 1,5 G SUSPENSION ORAL1500 mg · Suspensión oral | Almagato | Spain | Marketed | 2020 |
| ALMAGATO STADAPHARM 500 MG COMPRIMIDOS MASTICABLES500 mg · Comprimido masticable | Almagato | Spain | Marketed | 2020 |
| ALMOTRIPTAN STADA 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG12.5 mg · Comprimido recubierto con película | Almotriptan | Spain | Marketed | 2014 |
| ALOPURINOL STADA 100 MG COMPRIMIDOS EFG100 mg · Comprimido | Allopurinol | Spain | Marketed | 2020 |
| ALOPURINOL STADA 300 MG COMPRIMIDOS EFG300 mg · Comprimido | Allopurinol | Spain | Marketed | 2020 |
| ALOPURINOL STADAFARMA 100 MG COMPRIMIDOS EFG100 mg · Comprimido | Allopurinol | Spain | Authorised | 2025 |
| ALOPURINOL STADAFARMA 200 MG COMPRIMIDOS EFG200 mg · Comprimido | Allopurinol | Spain | Authorised | 2025 |
| ALOPURINOL STADAFARMA 300 MG COMPRIMIDOS EFG300 mg · Comprimido | Allopurinol | Spain | Authorised | 2025 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 838 | 672 | 166 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.